相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ruthenium (II) Catalyzed C(sp2)-H Bond Alkenylation of 2-Arylbenzo[d]oxazole and 2-Arylbenzo[d]thiazole with Unactivated Olefins
Bhavin Pipaliya et al.
CHEMISTRY-AN ASIAN JOURNAL (2021)
Ruthenium(III) complexes with imidazole ligands that modulate the aggregation of the amyloid-β peptide via hydrophobic interactions
Gideon K. Yawson et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2021)
Utilization of Guanidine-Based Ancillary Ligands in Arene-Ruthenium Complexes for Selective Cytotoxicity
Jit Karmakar et al.
ACS OMEGA (2021)
Importance of Hydrogen Bonding: Structure-Activity Relationships of Ruthenium(III) Complexes with Pyridine-Based Ligands for Alzheimer's Disease Therapy
Brendan J. Wall et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Metal complexes that bind to the amyloid-β peptide of relevance to Alzheimer's disease
Luiza M. F. Gomes et al.
COORDINATION CHEMISTRY REVIEWS (2020)
Design, synthesis, characterization and evaluation of the anticancer activity of water-soluble half-sandwich ruthenium(ii) arene halido complexes
Tanveer A. Khan et al.
NEW JOURNAL OF CHEMISTRY (2020)
Ruthenium(III) complexes containing thiazole-based ligands that modulate amyloid-β aggregation
Samantha E. Huffman et al.
METALLOMICS (2020)
Proteomic analysis of theS. cerevisiaeresponse to the anticancer ruthenium complex KP1019
Laura K. Stultz et al.
METALLOMICS (2020)
NAMI-A preferentially reacts with the Sp1 protein: understanding the anti-metastasis effect of the drug
Siming Yuan et al.
CHEMICAL COMMUNICATIONS (2020)
2020 Alzheimer's disease facts and figures
[Anonymous]
ALZHEIMERS & DEMENTIA (2020)
Widely Exploited, Yet Unreported: Regiocontrolled Synthesis and the Suzuki-Miyaura Reactions of Bromooxazole Building Blocks
Vitalii V. Solomin et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2019)
Histidine Targeting Heterobimetallic Ruthenium(II)-Gold(I) Complexes
Lucinda K. Batchelor et al.
INORGANIC CHEMISTRY (2019)
Ruthenium - A Non-essential Element that May Become Essential in Treating Chemoresistant Cancers
Paul J. Dyson
CHIMIA (2019)
NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
Enzo Alessio et al.
MOLECULES (2019)
Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders
Youssef H. El-Hayek et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Metal Ion Binding to the Amyloid β Monomer Studied by Native Top-Down FTICR Mass Spectrometry
Frederik Lermyte et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2019)
Strategies Employing Transition Metal Complexes To Modulate Amyloid-β Aggregation
Jong-Min Suh et al.
INORGANIC CHEMISTRY (2019)
Modification of Aβ Peptide Aggregation via Covalent Binding of a Series of Ru(III) Complexes
Luiza M. F. Gomes et al.
FRONTIERS IN CHEMISTRY (2019)
Synthesis, characterisation, molecular docking, biomolecular interaction and cytotoxicity studies of novel ruthenium(II)-arene-2-heteroarylbenzoxazole complexes
Sourav De et al.
NEW JOURNAL OF CHEMISTRY (2019)
(Pyridyl)benzoazole ruthenium(III) complexes: Kinetics of ligand substitution reaction and potential cytotoxic properties
Reinner Ochola Omondi et al.
INORGANICA CHIMICA ACTA (2018)
Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective
Enzo Alessio
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2017)
Photochemical Properties and Structure-Activity Relationships of RuII Complexes with Pyridylbenzazole Ligands as Promising Anticancer Agents
Dmytro Havrylyuk et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2017)
Organoruthenium(II) compounds with pyridyl benzoxazole/benzthiazole moiety: studies on DNA/protein binding and enzyme mimetic activities
Asaithambi Gomathi et al.
JOURNAL OF COORDINATION CHEMISTRY (2017)
Characterizing activation mechanisms and binding preferences of ruthenium metallo-prodrugs by a competitive binding assay
Christian Artner et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2017)
GRP78 at the Centre of the Stage in Cancer and Neuroprotection
Caty Casas
FRONTIERS IN NEUROSCIENCE (2017)
Thioflavin T as an amyloid dye: fibril quantification, optimal concentration and effect on aggregation
Christine Xue et al.
ROYAL SOCIETY OPEN SCIENCE (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials
Leli Zeng et al.
CHEMICAL SOCIETY REVIEWS (2017)
Towards an understanding of amyloid-β oligomers: characterization, toxicity mechanisms, and inhibitors
Shin Jung C. Lee et al.
CHEMICAL SOCIETY REVIEWS (2017)
Zinc(II) Binding Site to the Amyloid-β Peptide: Insights from Spectroscopic Studies with a Wide Series of Modified Peptides
Bruno Alies et al.
INORGANIC CHEMISTRY (2016)
Inhibition of adhesion, migration and of α5β1 integrin in the HCT-116 colorectal cancer cells treated with the ruthenium drug NAMI-A
Chiara Pelillo et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
X-ray Structure Analysis of Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) Bound to Human Serum Albumin Reveals Two Ruthenium Binding Sites and Provides Insights into the Drug Binding Mechanism
Aleksandar Bijelic et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Amberlite IR-120(H)-mediated on water synthesis of novel anticancer ruthenium(II)-p-cymene 2-pyridinylbenzothiazole (BTZ), 2-pyridinylbenzoxazole (BOZ) & 2-pyridinylbenzimidazole (BIZ) scaffolds
Sunisha Kottukulam Subran et al.
NEW JOURNAL OF CHEMISTRY (2016)
Upregulation of Glucose-Regulated Protein 78 in Metastatic Cancer Cells Is Necessary for Lung Metastasis Progression
Michael M. Lizardo et al.
NEOPLASIA (2016)
Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in- human, open-label, dose-escalation phase I study with expansion cohort
Howard A. Burris et al.
ESMO OPEN (2016)
Albumin binding and ligand-exchange processes of the Ru( III) anticancer agent NAMI-A and its bis-DMSO analogue determined by ENDOR spectroscopy
Michael I. Webb et al.
DALTON TRANSACTIONS (2015)
Modulation of the Aβ peptide aggregation pathway by KP1019 limits Aβ-associated neurotoxicity
Michael R. Jones et al.
METALLOMICS (2015)
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
Suzanne Leijen et al.
INVESTIGATIONAL NEW DRUGS (2015)
Metal Ions and Intrinsically Disordered Proteins and Peptides: From Cu/Zn Amyloid-β to General Principles
Peter Faller et al.
ACCOUNTS OF CHEMICAL RESEARCH (2014)
Modulation of Amyloid-β Aggregation by Histidine-Coordinating Cobalt(III) Schiff Base Complexes
Marie C. Heffern et al.
CHEMBIOCHEM (2014)
Synthetic Methods for the Preparation of Platinum Anticancer Complexes
Justin J. Wilson et al.
CHEMICAL REVIEWS (2014)
Cationic triruthenium(III) oxo complexes of the type [Ru3O(OAc)6L3]+ containing imidazole, pyrazole, thiazole and oxazole ligands: Synthesis, molecular structure, and cytotoxicity
Jiri Tauchman et al.
INORGANICA CHIMICA ACTA (2014)
Chiral Metallohelical Complexes Enantioselectively Target Amyloid β for Treating Alzheimer's Disease
Meng Li et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Why Alzheimer trials fail: removing soluble oligomeric beta amyloid is essential, inconsistent, and difficult
William I. Rosenblum
NEUROBIOLOGY OF AGING (2014)
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Robert Trondl et al.
CHEMICAL SCIENCE (2014)
Untangling Amyloid-β, Tau, and Metals in Alzheimer's Disease
MG Savelieff et al.
ACS CHEMICAL BIOLOGY (2013)
The Aggregation Potential of the 1-15-and 1-16-Fragments of the Amyloid β Peptide and Their Influence on the Aggregation of Aβ40
M. Shabestari et al.
APPLIED MAGNETIC RESONANCE (2013)
Structural insights into the interaction of platinum-based inhibitors with the Alzheimer's disease amyloid-β peptide
Victor A. Streltsov et al.
CHEMICAL COMMUNICATIONS (2013)
Biotransformations of Anticancer Ruthenium(III) Complexes: An X-Ray Absorption Spectroscopic Study
Aviva Levina et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
Alzheimer disease in the United States (2010-2050) estimated using the 2010 census
Liesi E. Hebert et al.
NEUROLOGY (2013)
EPR as a probe of the intracellular speciation of ruthenium(III) anticancer compounds
Michael I. Webb et al.
METALLOMICS (2013)
Synthesis, characterization and X-ray crystal structures of ruthenium polypyridyl and 2-(2′-hydroxyphenyl)-benzoxazole complexes: Reactivity with 1-methylimidazole, purine, glutathione and CT-DNA
John Novales et al.
POLYHEDRON (2013)
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism
Samuel I. A. Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Promising in Vitro anti-Alzheimer Properties for a Ruthenium(III) Complex
Luigi Messori et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Facile Methodology for Monitoring Amyloid-β Fibrillization
Nathan P. Cook et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Dye-Binding Assays for Evaluation of the Effects of Small Molecule Inhibitors on Amyloid (Aβ) Self-Assembly
Laramie P. Jameson et al.
ACS CHEMICAL NEUROSCIENCE (2012)
The influence of lipophilicity in drug discovery and design
John A. Arnott et al.
EXPERT OPINION ON DRUG DISCOVERY (2012)
Pyridine Analogues of the Antimetastatic Ru(III) Complex NAMI-A Targeting Non-Covalent Interactions with Albumin
Michael I. Webb et al.
INORGANIC CHEMISTRY (2012)
Approaching tumour therapy beyond platinum drugs Status of the art and perspectives of ruthenium drug candidates
A. Bergamo et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
A SAR Study of Novel Antiproliferative Ruthenium and Osmium Complexes with Quinoxalinone Ligands in Human Cancer Cell Lines
Werner Ginzinger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Control of ligand-exchange processes and the oxidation state of the antimetastatic Ru(III) complex NAMI-A by interactions with human serum albumin
Michael I. Webb et al.
DALTON TRANSACTIONS (2011)
A phase I dose-escalation study of NKP-1339 in patients with advanced solid tumors refractory to treatment.
N. R. Dickson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Molecular mechanism of Thioflavin-T binding to amyloid fibrils
Matthew Biancalana et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Ru(η6-arene) complexes of combretastatin-analogous oxazoles with enhanced anti-tumoral impact
Bernhard Biersack et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
fac-{Ru(Co)3}2+ Selectively Targets the Histidine Residues of the β-Amyloid Peptide 1-28. Implications for New Alzheimer's Disease Treatments Based on Ruthenium Complexes
Daniela Valensin et al.
INORGANIC CHEMISTRY (2010)
Oxidative Cyclization of a Phenolic Schiff Base and Synthesis of a Cyclometalated Ruthenium Nitrosyl Complex: Photoinduced NO Release by Visible Light
Kaushik Ghosh et al.
INORGANIC CHEMISTRY (2010)
Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339
Petra Heffeter et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2010)
Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study
Frederike Lentz et al.
ANTI-CANCER DRUGS (2009)
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Howard Jay Aizenstein et al.
ARCHIVES OF NEUROLOGY (2008)
KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
Christian G. Hartinger et al.
CHEMISTRY & BIODIVERSITY (2008)
The dichotomy in the DNA-binding behaviour of ruthenium(II) complexes bearing benzoxazole and benzothiazole groups
Catriona B. Spillane et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2008)
Metal-Ligand Exchange Kinetics in Platinum and Ruthenium Complexes SIGNIFICANCE FOR EFFECTIVENESS AS ANTICANCER DRUGS
Jan Reedijk
PLATINUM METALS REVIEW (2008)
Amyloid fibrils Abnormal protein assembly
Roma N. Rambaran et al.
PRION (2008)
Exploring chemical space with organometallics: Ruthenium complexes as protein kinase inhibitors
Eric Meggers et al.
SYNLETT (2007)
Copper binding to the amyloid-β (Aβ) peptide associated with Alzheimer's disease -: Folding, coordination geometry, pH dependence, stoichiometry, and affinity of Aβ-(1-28):: Insights from a range of complementary spectroscopic techniques
CD Syme et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp=5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine)
AH Velders et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent
JM Rademaker-Lakhai et al.
CLINICAL CANCER RESEARCH (2004)
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
R Kayed et al.
SCIENCE (2003)
A kinetic study of the chemical stability of the antimetastatic ruthenium complex NAMI-A
M Bouma et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
分享论文
